Clinical Trials – Page 21

Amgen’s Mixed Results: A Tale of Two Readouts in Eczema and Myasthenia Gravis Trials

10 months ago talkbio0Tagged amgen, Biotechnology, Clinical Trials, Drug Industry, Eczema, Myasthenia Gravis, Rocatinlimab

Amgen, Clinical Trials, Eczema, Myasthenia Gravis, Rocatinlimab, Uplizna, Biotechnology, Pharmaceutical Industry

Headlands Research Expands with New Clinical Trial Site in El Paso, Texas

10 months ago talkbio0Tagged Clinical Research, Clinical Trial Site, Clinical Trials, Diversity, El Paso, Medical Research activity, research, Texas

Headlands Research, clinical trial site, El Paso, Texas, diversity in clinical research, clinical trials, medical research

Wave Life Sciences Reports Positive Interim Data for Duchenne Muscular Dystrophy Treatment

10 months ago talkbio0Tagged Clinical Trials, DMD, Does skip, Duchenne, Dystrophin, exon 53, FORWARD-53, Gene Expression, Interim, Muscular Dystrophy, Muscular Dystrophy, Duchenne, Wave Life Sciences, WVE-N531

Wave Life Sciences, Duchenne Muscular Dystrophy, DMD, Exon 53 Skipping, WVE-N531, FORWARD-53 Clinical Trial, Interim Data, Muscle Health, Dystrophin Expression

Metsera’s Long-Acting GLP-1 Drug Shows Promising 7.5% Weight Loss in 36 Days, Paving Way for Monthly Dosing

10 months ago talkbio0Tagged Clinical Trials, dosing, Glucagon-Like Peptide 1, long-acting drug, MET-097, Metsera, monthly, Monthly (qualifier value), Obesity

Metsera, GLP-1, obesity treatment, long-acting drug, weight loss, monthly dosing, MET-097, clinical trial results.

Biohaven Revives Troriluzole Hopes with Positive Update for Spinocerebellar Ataxia

10 months ago talkbio0Tagged Ataxia, Spinocerebellar, Clinical Trials, Infrequent, Neurodegenerative Disorders, New Drug Application, SCA, Troriluzole, United States Food and Drug Administration

Troriluzole, Spinocerebellar Ataxia (SCA), Biohaven Pharmaceuticals, Neurodegenerative Disorders, FDA New Drug Application (NDA), Clinical Trials, Rare Diseases

Navigating Complex Regulatory Landscapes: The Importance of External Support for Biotech Sponsors in IRB, IBC, DMCs, and EACs

10 months ago talkbio0Tagged 6-aminocaproic acid, Biotech sponsors, Clinical Trials, Clinical Trials Data Monitoring Committees, DMCs, Ethics Advisory Committees, Ethics Committees, Research, gene therapy, IBC, Institutional Biosafety Committee, Regulatory Compliance, research, Risk Management

Biotech sponsors, IRB (Institutional Review Board), IBC (Institutional Biosafety Committee), DMCs (Data Monitoring Committees), EACs (Ethics Advisory Committees), Regulatory compliance, Clinical trials, Gene therapy research, Risk management